Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
InsideHMSA November, 2001 News, Views and Insights From Hitachi Medical Systems America, Inc. n this issue of Inside HMSA, the focus is on our Scanogram section that includes techniques, applications and news of interest for Hitachi users. Inside you will find a feature article on breast imaging, including proper coil selection, pulse sequences, how to image the augmented breast versus imaging for breast cancer and post-processing steps. Another feature article will detail contrastenhanced MR angiography (CE-MRA), including step-by-step instructions and helpful tips on how to successfully complete this exam. I You’ll also find articles detailing how HMSA assists each customer with ACR site accreditation, including information about the ACR’s new MRI Quality Control Program. For your convenience, we have published some Web sites where you can find information about MR safety and also information about MR educational and training programs that may be of interest to you. See our December issue for comprehensive product information, including what features were introduced at RSNA 2001. MR Imaging of the Breast Kathy Hampton, RT(R)(MR) Education Coordinator-MRI R Imaging is a powerful tool that shows promise in evaluating the breast due to its excellent softtissue contrast and multiplanar capabilities. Unfortunately, it has not been universally accepted for the diagnosis of breast cancers and other abnormalities. While the sensitivity is high, the specificity has been more variable, due to differences in system software and image interpretation. MR has shown its true strength in assessing breast implant integrity. M The number one indication for MR of the breast is for implant integrity. MR is the ONLY imaging modality that can diagnose intracapsular rupture of silicone implants. MR can also help with staging breast cancer, as well as evaluating the response to radiation or chemotherapy.1 Good spatial resolution, that is, thin slices, small pixels, is important, as is temporal resolution (short scan times). Both can be achieved on Hitachi systems. 3D imaging is helpful, as it allows for very thin, contiguous slices and high signal-to-noise. 3D imaging can be performed pre- and post-contrast using an RF Spoiled SARGE (RSSG) pulse sequence for a T1-weighted acquisition. Temporal resolution can be achieved with 2D dynamic imaging. Scan times can be very short, as a limited number of slices will be obtained at predetermined intervals. Coil selection is important for a desirable outcome. A dedicated breast coil should be the first choice for imaging, followed by a surface coil. Hitachi offers a dedicated bilateral quadrature breast coil, which allows bilateral or unilateral imaging with high signal-tonoise. Customers can use their large latchable extremity coil for breast imaging, however the use of this coil limits the exam to unilateral breast imaging. Regardless of the coil used, it is necessary to properly position the patient for the exam. The bilateral QD breast coil offers foolproof positioning of the coil and patient. First, remove all table pads, placing the coil directly on the table. Position the patient prone, headfirst, making sure that the breasts are lying in the hollowed out portion of the coil. It may be necessary to use the cushions that come with the coil to fill up any portion of the coil not occupied by the breast. Place appropriate pads for patient comfort and have the patient’s arms either alongside the body or up towards the head. The high signal-to-noise that this coil offers, combined with the ability to image both breasts simultaneously, makes this coil the best choice for the job. Continued on page 2 Continued from page 1 Inside Inside HMSA Contrast-Enhanced Magnetic Resonance Angiography pp. 4-5 Just the FAQ’s pp. 5-6 ACR MRI Site Accreditation and MRI Quality Control Program pp. 6-7 Continuing Education pp. 7-8 MRI Safety p. 8 Interested in Authoring an Article? p. 8 Quadrature breast coil with patient and coil in proper position. If the latchable extremity coil is used, you can only scan one breast at a time. To properly position your patient using this coil, first place the appropriate table pads on the table so that when the patient lies down, the breast will be at isocenter coronally. Next, position the patient with the affected side down, arm above the head. Roll the patient back until she is comfortable, placing cushions under the back for support. Next, place the coil adjacent to the breast, securing it with the table straps and ensuring that the coil remains perpendicular to the magnetic field. Pulse sequences differ according to the diagnosis. A study to rule out implant rupture may include T2 FSE to differentiate between implant and normal breast tissue and to assess the placement and integrity of the implant. On a T2- weighted image, silicone has higher signal intensity than any other tissue. An Inversion Recovery sequence to suppress fat (T1 100-110 ms) or silicone (200-220 ms) is also helpful. A FatSep™ pulse sequence, if the system is equipped, is also beneficial. The FatSep acquisition provides the radiologist with a post-processed fat- and a watersuppressed image. The usual scan planes are sagittal and axial since the radiologist may compare the MR images to previous mammograms.2 The breasts may also be imaged in the coronal plane. Contrast is normally not indicated for implant ruptures. T2-weighted FSE sagittal image acquired with the latchable extremity coil. Latchable extremity coil in proper position. Note that the patient’s anatomy is at isocenter coronally. 2 A study to rule out suspicious lesions will utilize a different protocol altogether. Remember to mark any palpable mass with a Vitamin E capsule or MR marker. It is helpful to start an IV prior to imaging to decrease the chance of patient motion. Precontrast imaging will most likely include a T2-weighted FSE, an Inversion Recovery sequence and a T1-weighted slice locations and then compared the contrast enhancement over time.4 Breast imaging may be confusing at this point. Malignant lesions show enhancement, but benign lesions may also enhance. Normal breast tissue may even enhance if the scan takes place during the proliferative phase of the menstrual cycle.3 This is the main reason why MR of the breast for lesion detection has not gained wide acceptance. There tends to be many false positives and some false negatives. T2-weighted FSE sagittal image of the augmented breast, demonstrating rupture of the implant. This exam was done with the QD breast coil. 3D Gradient Echo sequence (RSSG). 3D acquisitions are a good choice because they can be reconstructed in any plane after the exam is complete. Contrastenhanced sequences are usually indicated. 2D dynamic scanning can help assess contrast uptake in the lesion, and it may be helpful to repeat the 3D RSSG post-contrast sequence. Along with comparing the MR images with standard film-screen mammograms, the radiologist may find it helpful to post-process and/or analyze the images. It may be easier for the radiologist to appreciate an enhancing lesion if the pre-contrast images are subtracted from the post-contrast acquisition. Malignant lesions tend to have irregular spiculated margins. They tend to enhance very rapidly, especially along the edges and then washout quickly. Benign lesions that enhance will have well-defined borders and tend to show slow and progressive enhancement over time. There is literature that describes the rate and pattern of enhancement of malignant versus benign lesions. In order to “see” these patterns, the radioT2-weighted FSE TRS image of the breast. Demonstrates intracapsular logist may place rupture of the implant. an ROI over the area Dynamic imaging of the breast allows of greatest enhancement2 and then easy comparison of contrast enhancereview graphs that display the ment over time. One study repeated enhancement rates over time. The T1-weighted acquisitions at 1, 3, and data, graphically displayed, can 5 minutes post-injection at the same sometimes aid the radiologist in 3 determining whether the lesion shows signs of malignancy based on enhancement patterns. Hitachi has included this analysis software on all of its systems. There are three types of graphs: • Time-Intensity Curve (Normalize) This graph displays the TimeIntensity curve of the differential value of different ROIs over time. • Time-Intensity Curve (Ratio) This graph displays the TimeIntensity curve of the ratio between the pre- and post-contrast image sets. • Time-Difference Curve This graph displays the speed of enhancement or the time difference between the pre- and post-contrast image sets. Most enhancing lesions in the breast will not be malignant2, but biopsies will still be performed for these suspicious lesions. New coil technology, such as interventional breast coils for MR biopsy are being investigated, as are new pulse sequences to help increase the specificity of MR. As techniques, software and hardware improve and evolve, confidence in this modality should increase. 1 Soo, M, Spritzer, C. MR Imaging of the Breast. Applied Radiology, p. 18, September 1996. 2 Orel, S. Differentiating Benign from Malignant Enhancing Lesions Identified at MR Imaging of the Breast: Are TimeSignal Intensity Curves an Accurate Predictor? Radiology, p. 1, April 1999. 3 Matzko, J. Contrast-enhanced MR of the breast: Evolving roles. Applied Radiology, p. 47, March 1995. 4 Obdeijn, I, et al. MR Lesion Detection in a Breast Cancer Population. JMRI, p. 850, November/December 1996.